Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Item
http://www.wikidata.org/entity/Q35715691
Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients.Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells.Preserving residual renal function in dialysis: what we know.Immunologic Effects of the Renin-Angiotensin System.The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel?Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study).C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1.Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.
P2860

Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Item
http://www.wikidata.org/entity/Q35715691
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Comparative effects of angiote ...... lammation during hemodialysis.
@ast
Comparative effects of angiote ...... lammation during hemodialysis.
@en
type
label
Comparative effects of angiote ...... lammation during hemodialysis.
@ast
Comparative effects of angiote ...... lammation during hemodialysis.
@en
prefLabel
Comparative effects of angiote ...... lammation during hemodialysis.
@ast
Comparative effects of angiote ...... lammation during hemodialysis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Comparative effects of angiote ...... flammation during hemodialysis
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932